Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects

被引:0
|
作者
Nicholas, TW
Read, SB
Burrows, FJ
Kruse, CA
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Immunol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA
[3] Chiron Technol Ctr Gene Therapy, San Diego, CA USA
关键词
glioma; connexin; gap junctions; suicide gene therapy; bystander effect;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Connexins are proteins that form gap junctions between cells in various mammalian tissues. Because of their role in intercellular communication, connexins are important in the bystander cell death seen in Herpes simplex virus-thymidine kinase (HSV-TK) gene therapy for brain tumors. A selective review of connexin transduction/transfection studies with particular emphasis to central nervous system tumor cells is presented. In addition, specific references to studies with cell types that demonstrate low gap junction intercellular communication are presented. Data are included with the HT-29 colorectal tumor cell line to support the concept that enhancing gap junction protein expression in otherwise low gap junction communicating HT-29 cells increases bystander cell death and reduces tumor burden beyond what might be expected from HSV-TK and ganciclovir (GCV) treatment alone. Maximum in vitro bystander cell death was always produced when GCV treated co-cultures of TK-transduced and non-TK-transduced HT-29 cell lines were also transduced with connexin-43. When connexin was present in only one group of cells in the co-culture, there was more bystander cell death observed with connexin transduced into the non- TK-transduced cells, rather than the TK-transduced cells. The data presented reinforces conclusions made from earlier findings from cell line mixing experiments in which the non-TK-transduced cell population determined the level of bystander cell death (Burrows et al., 2002).
引用
收藏
页码:495 / 507
页数:13
相关论文
共 50 条
  • [31] Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression
    Pu, Ke
    Li, Shao-yi
    Gao, Yun
    Ma, Li
    Ma, Weining
    Liu, Yunhui
    BRAIN RESEARCH, 2011, 1369 : 245 - 252
  • [32] Bystander killing of uterine endometrial cancer cells by herpes simplex virus thymidine kinase is mediated by ganciclovir and retinoids
    Suzuki, Takahir
    Matsuura, Motoki
    Tanaka, Ryoichi
    Ito, Eiki
    Ryosaka, Miwa
    Saito, Tsuyoshi
    CANCER RESEARCH, 2009, 69
  • [33] Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase
    Kunishige, I
    Samejima, Y
    Shiki, T
    Moriyama, A
    Meruelo, D
    Saji, F
    Murata, Y
    GYNECOLOGIC ONCOLOGY, 1999, 72 (01) : 16 - 25
  • [34] Herpes simplex virus thymidine kinase gene/ganciclovir gene therapy for primary malignant glioma: Results of a phase III study
    Rainov, NG
    CANCER GENE THERAPY, 2000, 7 (08) : 1208 - 1208
  • [35] Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of esophageal squamous cancers
    Shi, Yaoping
    Wang, Jianfeng
    Bai, Zhibin
    Li, Yonggang
    Qiu, Longhua
    Zhai, Bo
    Zhang, Feng
    Yang, Xiaoming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (09): : 2054 - 2063
  • [36] Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy
    PD Boucher
    LJ Ostruszka
    PJM Murphy
    DS Shewach
    Gene Therapy, 2002, 9 : 1023 - 1030
  • [37] Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme
    Voges, J
    Weber, F
    Reszka, R
    Sturm, V
    Jacobs, A
    Heiss, WD
    Wiestler, O
    Kapp, JF
    HUMAN GENE THERAPY, 2002, 13 (05) : 675 - 685
  • [38] Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats
    Engelmann, C
    Panis, Y
    Bolard, J
    Diquet, B
    Fabre, M
    Nagy, H
    Soubrane, O
    Houssin, D
    Klatzmann, D
    HUMAN GENE THERAPY, 1999, 10 (09) : 1545 - 1551
  • [39] Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy
    Boucher, PD
    Ostruszka, LJ
    Murphy, PJM
    Shewach, DS
    GENE THERAPY, 2002, 9 (15) : 1023 - 1030
  • [40] Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system
    Hayashi, K
    Hayashi, T
    Sun, HD
    Takeda, Y
    HUMAN GENE THERAPY, 2002, 13 (03) : 415 - 423